Crosslinked Hydrogel Graft Coating to Minimize Tissue Adhesions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Hernia repair often results in soft tissue adhesions due to tissue drying, irritation, or friction against implanted grafts, complicating future surgeries and causing abdominal pain.

Innovation Solution

A medical graft with a lubricious coating comprising cross-linked matrix proteins and additives like hyaluronic acid, sodium hyaluronate, and chondroitin sulfate, which reduces adhesion formation by forming diphenolic crosslinks between matrix proteins and the substrate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a hernia mesh graft is implanted for repair, then structural support is provided, but soft tissue adhesions form on the graft surface

Engineering Contradiction:
Improvestructural supportVSAvoidadhesion formation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies a coating layer comprising cross-linked matrix proteins (such as collagen, gelatin, or elastin) on the graft surface. This coating acts as an intermediary between the synthetic graft material and the surrounding soft tissue, preventing direct contact and adhesion formation while maintaining the structural support function of the underlying graft.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite structure by combining the synthetic graft material with a biological coating layer of cross-linked matrix proteins. This composite approach integrates the mechanical strength of synthetic materials with the biocompatibility and anti-adhesive properties of natural extracellular matrix components.

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If tissue is dried during surgery, then handling becomes easier, but adhesion formation increases

Engineering Contradiction:
Improvetissue handlingVSAvoidadhesion formation
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The coating of cross-linked matrix proteins is applied to the graft surface before implantation. This preliminary protective layer is already in place when the graft is implanted, preventing adhesion formation from the outset without requiring additional intraoperative steps that might involve tissue drying.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If friction occurs between organs and implanted graft, then adhesion forms, but future surgery becomes more difficult

Engineering Contradiction:
Improveinitial surgical outcomeVSAvoidfuture surgical complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The cross-linked matrix protein coating serves as a permanent intermediary layer on the graft surface that reduces friction between moving organs and the implant. This prevents adhesion formation that would otherwise complicate future surgeries, while the coating itself remains stable and maintains the initial surgical outcome.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The coating significantly minimizes adhesions upon implantation, improving surgical outcomes by reducing surgery time and difficulty and potentially alleviating abdominal pain.

Implementation Method 1

The coating comprises a composition of cross-linked matrix proteins having diphenolic crosslinks between individual matrix proteins within the coating material, and diphenolic crosslinks between matrix proteins and the substrate

Methodology Applied
Scientific EffectDiphenolic crosslinking: Chemical Bonding

Data Source

PatentUS20250367350A1Crosslinked hydrogel coated medical grafts
Publication Date: 2025.12.04 COOK BIOTECH INC
  • US20250367350A1 patent drawing
  • US20250367350A1 patent drawing
  • US20250367350A1 patent drawing

AI summary

In certain embodiments, the present disclosure provides medical graft devices having covalently crosslinked matrix protein hydrogel coatings. In some forms, such coatings are configured to reduce the formation of adhesions upon implantation.